HOME >> BIOLOGY >> NEWS
Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting

RESTON, Va. -- The potential of molecular imaging and therapy and the power of nuclear medicineand their impact on patient carewill be explored as more than 4,000 doctors, technologists, scientists and pharmacists from around the world attend SNMs 54th Annual Meeting June 26 in Washington, D.C. SNMan international, multidisciplinary society of more than 16,000 molecular imaging and nuclear medicine professionals in 78 countriesannually showcases research that promises to revolutionize health care.

"SNM has embarked on a mission to improve health care by advancing molecular imaging and therapy, and our program features an increased presence of related research," said SNM President Martin P. Sandler. "Molecular imagingthe use of state-of-the-art imaging technologies (such as PET, SPECT, MRI and others) to "photograph" biological targets or pathways in the bodyand its therapy value will be at the forefront of personalized medicine, eventually providing patient-specific information that allows tailored treatment of disease," he added.

"Nearly 2,000 scientific and technologist studies will be presented during this meeting, offering a look at molecular imaging and nuclear medicine research leading to improvements in the diagnosis and treatment of life-threatening cancer, heart disease and brain disorders," said Scientific Program Committee Chair Frederic H. Fahey. "A new feature this year is the InfoSNM program, which will allow attendees to participate in interactive computer presentations and educational offerings on the novel applications of computers and information science in molecular imaging and nuclear medicine," explained Fahey. Also new will be the Molecular Imaging Gateway, an area devoted specifically to this exciting field sponsored by the societys Molecular Imaging Center of Excellence.

"As molecular imaging becomes a significant force in clinical practice, SNM Technologist Section members will assume an expanded role in med
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
29-Mar-2007


Page: 1 2 3

Related biology news :

1. Advances in Optics for Biotechnology, Medicine and Surgery
2. Advances in Forest Threat Assessment: Applications to Forest and Rangeland Management
3. Advances in the characterisation of the oyster mushroom genes
4. ChemGenex reports successful personalized dosing of Quinamed at ASCO
5. Faster, low cost sequencing technologies needed to drive era of personalized medicine
6. Physicians face significant new liability risks with advent of personalized medicine era
7. Encouraging results from validation study of trial of personalized treatment in breast cancer
8. Computer graphics spills from milk to medicine
9. New survey documents the headaches of computerized medicine
10. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
11. Nanotechnology, medicine and bioethics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... MONTEREY, Calif. , March 3, 2016 /PRNewswire/ ... Partner, launched this week highlighting advancements in flexible, ... – a record setting attendance - have gathered ... in this fast-growing field of electronics. The Flex ... a focal point for companies, R&D organizations, and ...
(Date:3/2/2016)... March 2, 2016 ... addition of the  "Global Biometrics Market in ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global biometrics ... at a CAGR of around 27%   ... has announced the addition of the  "Global ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress ... hair loss, Nutrafol® has captured the hearts of key opinion leaders in the ...
(Date:5/3/2016)... ... 03, 2016 , ... Leading CEOs from biotech, pharmaceutical, and ... June 1st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/3/2016)... -- - And Other Rising Companies - ... Competitor Biologics  - Biosimilar Drug Producers - ... Who are the most important and promising ... sales potentials? Discover, in our updated survey, organisations, outlooks ... revenue forecasting. Visiongain,s new study ...
Breaking Biology Technology:
Cached News: